FDA Abandons Proposal For Interactive, “Pre-Decisional” IDE
This article was originally published in The Gray Sheet
Executive Summary
The agency finalized a guidance document on investigational device exemption review decisions, dropping a proposal to establish a new, interactive “pre-decisional” IDE process. Industry had been skeptical that the proposed program would improve efficiency of study reviews, and worries that it would require a lot of FDA resources.